iScience (Apr 2021)

Semaphorin3E-PlexinD1 signaling in coronary artery and lymphatic vessel development with clinical implications in myocardial recovery

  • Kazuaki Maruyama,
  • Kazuaki Naemura,
  • Yuichiro Arima,
  • Yasunobu Uchijima,
  • Hiroaki Nagao,
  • Kenji Yoshihara,
  • Manvendra K. Singh,
  • Akiyoshi Uemura,
  • Fumio Matsuzaki,
  • Yutaka Yoshida,
  • Yukiko Kurihara,
  • Sachiko Miyagawa-Tomita,
  • Hiroki Kurihara

Journal volume & issue
Vol. 24, no. 4
p. 102305

Abstract

Read online

Summary: Blood and lymphatic vessels surrounding the heart develop through orchestrated processes from cells of different origins. In particular, cells around the outflow tract which constitute a primordial transient vasculature, referred to as aortic subepicardial vessels, are crucial for the establishment of coronary artery stems and cardiac lymphatic vessels. Here, we revealed that the epicardium and pericardium-derived Semaphorin 3E (Sema3E) and its receptor, PlexinD1, play a role in the development of the coronary stem, as well as cardiac lymphatic vessels. In vitro analyses demonstrated that Sema3E may demarcate areas to repel PlexinD1-expressing lymphatic endothelial cells, resulting in proper coronary and lymphatic vessel formation. Furthermore, inactivation of Sema3E-PlexinD1 signaling improved the recovery of cardiac function by increasing reactive lymphangiogenesis in an adult mouse model of myocardial infarction. These findings may lead to therapeutic strategies that target Sema3E-PlexinD1 signaling in coronary artery diseases.

Keywords